Skip to content

Development and promotion of an AI-assisted tool for NVAF management in primary care

The application effect of an AI-assisted tool for NVAF management on the guideline adherence of anticoagulation in primary care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052307
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-10-25
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Intervention Group :Installing and using the AI-assisted tool in all GP consulting rooms
Control Group:Usual care

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Selection criteria for general practitioners: general practitioners working in community general practice clinics or atrial fibrillation specialist clinics; willing to participate in this study and complete preliminary training; 2. Inclusion criteria of patients: age 18 years and above; have a clear diagnosis of any type of atrial fibrillation in the past or when visiting a doctor; have signed a contract with a community doctor for at least 1 year; be willing to cooperate with the completion of this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for general practitioners: do not use computers or are unskilled in daily work; it is expected that they may retire within 1 year, may retire, take sick maternity leave, post transfer, etc. to complete the research, or may not be on duty for more than 1 month during the research period; 2. Exclusion criteria for patients: combined with terminal diseases such as advanced tumors, or the expected survival time is less than 1 year; illiteracy, dementia, etc.; patients with valvular atrial fibrillation or patients with artificial valves; participating in other clinical trials of atrial fibrillation ; Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
The proportion of antithrombotic treatment prescriptions in agreement with recommendations in the guidelines;

Secondary

MeasureTime frame
The compliance rate of INR in patients with warfarin;The stroke morbidity during follow-up;Treatment compliance of the subjects;Consultation satisfication of the subjects;The change of GPs' AF management ability;Cost - benefit analysis;The acceptance and reasonable optimal suggestions of GPs for the AI-assisted tool;Frequency of consultation;

Countries

China

Contacts

Public ContactPan Zhigang

Zhongshan Hospital, Fudan University

zhigang_pan@163.com+86 18616881251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026